Table 1.

Baseline Characteristics.

Variables	CTX group (n = 5) mean (STD) or frequency	RTX group (n = 23) mean (STD) or frequency	Group A (n = 10) mean (STD) or frequency	p-value
Age (years)	33 (7.80)	44 (20.55)	43 (13.4)	0.44
Gender (F/M)	5/0	13/10	7/3	0.169
Initial inhibitor level	1.98 (2.50)	2.97 (2.72)	2.30 (2.51)	0.73
Initial ADAMTS13 antibody level	37.5 (34.65)	33.83 (29.08)	N/A	0.89
D-Dimer	767.00 (202.34)	2255.57 (1801.57)	1590.75 (600.06)	0.31
Fibrinogen	264.40 (67.42)	302.95 (90.46)	319.00 (117.66)	0.63
Nadir platelet count	8.8 (2.28)	12.5 (8.6)	12.20 (7.36)	0.64
Absolute neutrophil count	7.1 (4.72)	8.8 (4.1)	6.97 (2.14)	0.55
Absolute lymphocyte count	1.61 (1.06)	2.07 (1.05)	1.91 (1.40)	0.70
Neutrophil-to-lymphocyte ratio	9.59 (12.59)	6.23 (5.85)	5.61 (4.09)	0.61
Creatinine on admission	1.02 (0.22)	1.93 (1.98)	3.03 (1.47)	0.31
Peak LDH on admission	1,444.4 (790.47)	1,222.91 (604.31)	926.20 (374.53)	0.41
Platelet normalization (days)	11.2 (7.73)	11.32 (11.41)	11.20 (16.13)	0.99
LDH normalization (days)	11.6 (6.62)	11.33 (10.6)	6.00 (3.16)	0.58
Resolution time (days)	14.6 (8.32)	14.5 (12.07)	12.80 (15.15)	0.96
Duration of hospitalization (days)	23.6 (9.29)	26.75 (15.98)	11.2 (6.72)	0.13
Altered mental status (Yes/ No)	2/3	8/13	2/2	0.91
Autoimmune disease (Yes/No)	3/2	3/20	2/8	0.07
Malignancy (Yes/No)	3/2	4/19	1/9	0.06